Coya Therapeutics logo

Coya Therapeutics

Houston, TX

Coya Therapeutics is a clinical-stage biotechnology company developing first-in-class and best-in-class approaches utilizing adoptive regulatory T cells (Tregs) to target disease. The company’s proprietary CTreg (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf’ approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAITM (Exosomes Against Inflammation) platforms, Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson’s, Alzheimer’s, FTD and autoimmune diseases.

coyatherapeutics.com

Company Details

Founded

2020

Employees

Between 1 - 10 employees

Raised

$51,800,000

Headquarters Location

Houston, TX

Public

Yes

Acquired

No

CEO

Howard BermanHoward Berman

Founders

Howard Berman
Howard Berman

Company Collections

These are collections Coya Therapeutics is a part of. Click on the collection name to view similar companies.

Coya Therapeutics' Tech Stack